Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRV vaccine immunogenicity study in Taiwanese infants who received hepatitis B immunoglobulin at birth
2011-003731-63Phase 4
- Sponsor
- GSK
- Start
- May 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of human rotavirus RIX4414 strain vaccine in rotaviral diarrhea, sponsored by GSK. Primary endpoint: Anti-rotavirus IgA antibody seroconversion rate.
02
Drugs
human rotavirus RIX4414 strain vaccine
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on 2011-003731-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003731-63.